Company Filing History:
2 out of 5 
1 out of 652 
Years Active: 2021-2025
Title: Innovations of Yangbo Feng in Neurodegenerative Disease Treatment
Introduction
Yangbo Feng is an accomplished inventor based in Malvern, PA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic compounds for neurodegenerative diseases. With a total of 2 patents, his work focuses on innovative solutions that target specific biological pathways.
Latest Patents
Feng's latest patents include groundbreaking inventions such as kinase inhibitors for the treatment of neurodegenerative diseases. These compounds are designed to specifically target kinases without inhibiting related enzymes, making them valuable for treating conditions like Alzheimer's disease and other neurodegenerative disorders. Additionally, his patent on histone deacetylase (HDAC) inhibitors outlines methods for modulating HDAC activity, which is crucial for addressing various cancers, inflammatory disorders, and neurodegenerative diseases.
Career Highlights
Throughout his career, Yangbo Feng has worked with notable organizations, including Reaction Biology Corporation and the Ohio State Innovation Foundation. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic strategies.
Collaborations
Feng has collaborated with esteemed colleagues such as Haiching Ma and Yuren Wang. These partnerships have further enriched his research endeavors and have led to the advancement of his patented technologies.
Conclusion
Yangbo Feng's innovative work in the field of neurodegenerative disease treatment showcases his commitment to improving therapeutic options for patients. His patents reflect a deep understanding of complex biological mechanisms and a dedication to advancing medical science.